Fairvalue-Calculator Fairvalue-Calculator
EN DE

Rafael Holdings (RFL) Fair Value & Analysis

Real Estate · US · Market cap $142M

Price$2.71
Fair Value$2.99
Upside+10.3%
Quality90/100
Evidence: Low Range $2.77 – $3.30

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Rafael Holdings (RFL) currently trades at $2.71, while our model-based Fair Value estimate is $2.99 — implying the stock looks roughly 10.3% undervalued today. We read business quality at 90/100 (high quality), in the Real Estate sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is Trappsol Cyclo, which is in phase 3 clinical trial being evaluated for the potential treatment of Niemann-Pick Disease Type C1 (NPC1), a rare, fatal and progressive genetic disorder; and CPI-613 (devimistat), a stable analog of normally transient, acylated catalytic intermediates of lipoate, which is in phase II of clinical trial. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1A and 1B clinical studies targeting patients with advanced cancers. In add…

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Rafael Holdings (RFL) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $2.99 versus a price of $2.71 — about +10% (undervalued). Model-based estimate, not financial advice.
What is the fair value of RFL?
Our 21-model fair value for Rafael Holdings is $2.99 (as of Jun 26, 2026), built from audited fundamentals. The current price is $2.71.
What is the quality score of RFL?
Rafael Holdings has a Quality Score of 90/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.